Drugs / CKD-828
last change Mar 2024 re-read 9 days ago

CKD-828

Developed for
hyperlipidemia · essential hypertension
Investigated by
Chong Kun Dang Pharmaceutical

Trials 13

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 112 trials
Phase 1 NCT06112678 Jan → Feb 2024 hyperlipidemia, hypertensive disorder Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05881707 Jul → Sep 2023 hypertensive disorder Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05834595 May → Jul 2023 hypertensive disorder Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05749861 Apr → Jun 2023 hyperlipidemia, combined, 2 Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05549401 Sep → Nov 2022 — Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05540912 Sep → Nov 2022 hypertensive disorder Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05192356 Feb → May 2022 hyperlipidemia, combined, 2 Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT04883658 Jun → Jul 2021 — Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT04660370 Jan → Feb 2021 hyperlipidemia, combined, 2 Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT04587206 Oct → Dec 2020 — Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 31 trial
Phase 3 NCT04388215 Oct 2019 → Apr 2021 essential hypertension, hyperlipidemia Chong Kun Dang Pharmaceutical Unknown No outcome recorded
Comparator or background therapy2 trials
Phase 1 NCT04304547 Comparator Feb → Apr 2020 — Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT04272502 Background Jun → Aug 2019 — Chong Kun Dang Pharmaceutical Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 15 sources stand behind the page.

FieldValueCited text
Known as CKD-828 “D326, D337 or CKD-828 for 9 days” NCT03726866 ↗
14

NCT04272502 ↗

NCT05881707 ↗

NCT04388215 ↗

NCT04660370 ↗

NCT04258865 ↗

NCT04304547 ↗

NCT05549401 ↗

NCT04883658 ↗

NCT05834595 ↗

NCT05192356 ↗

Show 4 more sources

Route Oral “QD, PO” NCT04258865 ↗